Cover Image
市場調查報告書

大腸癌:主要18個國家的市場預測

Epiomic Epidemiology Series: Colorectal Cancer Forecast in 18 Major Markets 2017-2027

出版商 Black Swan Analysis 商品編碼 479873
出版日期 內容資訊 英文 90 Pages
訂單完成後即時交付
價格
Back to Top
大腸癌:主要18個國家的市場預測 Epiomic Epidemiology Series: Colorectal Cancer Forecast in 18 Major Markets 2017-2027
出版日期: 2017年03月01日 內容資訊: 英文 90 Pages
簡介

本報告提供全球主要18個國家的大腸癌 (直腸大腸癌)的發病情形相關分析,疾病概要和目前的患病人數,各子類型及性別、各年代 (5歲區分)的詳細情況,各地區、各民族趨勢,風險要素,疾病診斷預後,主要的症狀和併發症 (腹瀉,直腸出血,腹部的不舒服 (抽筋、腹痛、膨脹感等)殘便感等),未來趨勢預測 (今後10年份) 的資訊彙整。

目錄

  • 圖表一覽
  • 簡介
  • 疾病的原因
  • 風險要素與預防法
  • 疾病診斷方法
  • 各地區/各民族的差異
  • 疾病的預後和臨床過程
  • 疾病相關的主要的共生病症/特徵
  • 患者數的測量方法
  • 大腸癌的最大患病人數
  • 大腸癌患者的癌症分期
    • 大腸癌患者的特徵
    • S字直腸癌患者的特徵
    • 直腸癌患者的特徵
  • 大腸癌患者的突然變異
  • 大腸癌患者的治療方法
  • 文中的簡稱一覽
  • Black Swan Analysis的其他出版刊物
  • Black Swan Analysis的線上、病患人數的資料庫
  • 病患人數的服務
  • 線上價格資料/平台
  • 參考文獻
  • 附錄

表格一覽

分析觀察對象國家

  • 阿根廷
  • 澳洲
  • 巴西
  • 加拿大
  • 中國
  • 法國
  • 德國
  • 印度
  • 義大利
  • 日本
  • 墨西哥
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 土耳其
  • 英國
  • 美國

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: CRCN0010317

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Colorectal Cancer in 18 Major Markets

Colorectal Cancer (CRC) affects the colon and rectum, which are a part of the large intestine. Colorectal cancer occurs when tumours, identified as polyps, develop in the lining of the large intestine. Some of these polyps can become cancerous over time (several years) but some of these polyps may not become malignant at all.

This report provides the current incident population for Colorectal Cancer across 18 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Brazil, Japan, India, China, Turkey, Mexico, Russia, Argentina, Australia, Saudi Arabia and South Africa) split by gender and 5-year age cohort. Along with the current incidence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Colorectal Cancer have been quantified and presented alongside the overall incidence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Colorectal Cancer include:

  • Change in bowel habits, including diarrhoea or constipation or a change in the consistency of stools
  • Rectal bleeding or blood in the stool
  • Persistent abdominal discomfort, such as cramps, gas or pain
  • A feeling that the bowel doesn't empty completely

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

  • Able to quantify patient populations in global Colorectal Cancer market to target the development of future products, pricing strategies and launch plans.
  • Gain further insight into the incidence of the subdivided types of Colorectal Cancer and identify patient segments with high potential.
  • Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
  • Provide a level of understanding on the impact from specific co-morbid conditions on Colorectal Cancer incident population.
  • Identify sub-populations within Colorectal Cancer which require treatment.
  • Gain an understanding of the specific markets that have the largest number of Colorectal Cancer patients.

Table of Contents

  • List of Tables and Figures
  • Introduction
  • Cause of the Disease
  • Risk Factors & Prevention
  • Diagnosis of the Disease
  • Variation by Geography/Ethnicity
  • Disease Prognosis & Clinical Course
  • Key comorbid conditions/Features associated with the disease
  • Methodology for quantification of patient numbers
  • Top-line incidence for Colorectal Cancer
  • Staging of Colorectal Cancer patients
    • Features of Colon Cancer patients
    • Features of rectosigmoidal cancer patients
    • Features of rectal cancer patients
  • Genetic mutations in Colorectal Cancer patients
  • Treatment of Colorectal Cancer patients
  • Abbreviations used in the report
  • Other Black Swan Analysis Publications
  • Black Swan Analysis Online Patient-Based Databases
  • Patient-Based Offering
  • Online Pricing Data and Platforms
  • References
  • Appendix

List of Figures

  • Progression from polyp to cancer

List of Tables

  • American Joint Committee on Cancer (AJCC) TNM Staging for Colorectal Cancer
  • Duke's Staging of Colorectal Cancer
  • Colorectal Cancer incidence, total (000s)
  • Colorectal Cancer incidence, males (000s)
  • Colorectal Cancer incidence, females (000s)
  • CRC patients by AJCC Tumour Stage, total (000s)
  • CRC patients by site, total (000s)
  • Colon cancer patients by AJCC Tumour Stage, total (000s)
  • Colon cancer patients by CEA level, total (000s)
  • Histopathology of Colon cancer patients, total (000s)
  • Rectosigmoidal cancer patients by AJCC Tumour Stage, total (000s)
  • Rectosigmoidal cancer patients by CEA level, total (000s)
  • Histopathology of Rectal cancer patients, total (000s)
  • CRC patients with KRAS mutation, total (000s)
  • CRC patients with BRAF mutation, total (000s)
  • CRC patients with PIK3CA mutation, total (000s)
  • CRC patients with PDL-1 over expression, total (000s)
  • CRC patients receiving adjuvant treatment, total (000s)
  • CRC patients receiving 1L (metastatic) treatment, total (000s)
  • CRC patients receiving 2L treatment, total (000s)
  • CRC patients receiving 3L+ treatment, total (000s)
  • Abbreviations and Acronyms used in the report
  • USA Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • USA Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Canada Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Canada Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • France Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • France Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Germany Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Germany Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Italy Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Italy Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Spain Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Spain Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • UK Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • UK Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Brazil Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Brazil Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Japan Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Japan Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • India Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • India Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • China Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • China Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Turkey Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Turkey Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Australia Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Australia Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Mexico Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Mexico Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Argentina Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Argentina Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Russia Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Russia Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • Saudi Arabia Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • Saudi Arabia Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
  • South Africa Incidence of Colorectal Cancer by 5-yr age cohort, males (000s)
  • South Africa Incidence of Colorectal Cancer by 5-yr age cohort, females (000s)
Back to Top